High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.

导出 OA

翻译打印收藏纠错

作者： Minzhi,Hou ^[1] ; Zhiqiang,Cheng ^[2] ; Hongwei,Shen ^[3] ; Shanyang,He ^[2] ; Yang,Li ^[2] ; Yunping,Pan ^[1] ; Chongjin,Feng ^[4] ; Xinlin,Chen ^[4] ; Yang,Zhang ^[5] ; Millicent,Lin ^[6] ; Liantang,Wang ^[7] ; Zunfu,Ke ^[1]

作者单位： Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China. ^[1] Department of Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China. ^[2] Department of Pathology, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, P.R. China. ^[3] Department of Stomatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China. ^[4] Department of Preventive Medicine and Biostatistics, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China. ^[5] Biomedical Engineering, University of Texas at El Paso, El Paso, Texas, USA. ^[6] Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA. ^[7]

关键词 CTHRC1 epithelial ovarian cancer epithelial-mesenchymal transition β-catenin